Predictors of Clinical Response to Intravenous Secukinumab Among Patients with PsA: A Post Hoc Analysis of a Phase 3 Trial

被引：0

作者：

Kivitz, Alan ^{[1
]}

Sedova, Liliana ^{[2
,3
]}

Churchill, Melvin ^{[4
]}

Vizcaya, Cynthia ^{[5
]}

Sutariya, Reema ^{[6
]}

Cao, Wenhao ^{[6
]}

Singhal, Atul ^{[7
]}

机构：

[1] Altoona Ctr Clin Res, Duncansville, PA USA

[2] Inst Rheumatol, Prague, Czech Republic

[3] Charles Univ Prague, Clin Rheumatol, Fac Med 1, Prague, Czech Republic

[4] Arthrit Ctr Nebraska, Lincoln, NE USA

[5] Novartis Pharma AG, Basel, Switzerland

[6] Novartis Pharmaceut, E Hanover, NJ USA

[7] Southwest Arthrit Res Grp, Mesquite, TX USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2354

引用

页码：4750 / 4752

页数：3